Clinical Trial Liaison, Pulmonology and Rare diseases

Job Title: Clinical Trial Liaison, Pulmonology and Rare diseases
Contract Type: Permanent
REF: 124195
Contact Email:
Job Published: over 1 year ago

Job Description

Clinical Trial Liaison, Pulmonology and Rare diseases
Our client is a fast-growing clinical stage biopharmaceutical company, with an exciting pipeline of drug compounds at an advanced stage in research are building the next generation biotech company. They have signed off on a newly created role of Clinical Trial Liaison for their rare disease programs in Pulmonology.

The successful candidate will work closely with Clinical Development and Clinical Operations, acting as a liaison between company colleagues, CRO partners and external clinical investigators, and providing site support.

The key focus for this hire will be to aide patient recruitment in the sponsor company’s Phase 2 and Phase 3 pulmonology rare disease clinical studies. In this role, you will resolve recruitment barriers as a company expert in communicating protocols specifics and queries, inclusion and exclusion criteria, and education the community on the company’s research studies.

This role will be responsible for the evaluation, initiation and engagement of clinical trial sites, investigators and study personnel in Europe, to aide enrolment into Phase 2 and Phase 3 sponsored studies.

The hire will ideally be based in Ireland and / or Mainland Europe, close to airport hub as easy access for travel to sites. Travel is mainly European region (assigned territory) and some other international travel.

Key remit for Clinical Trial Liaison:
Participate in the development of strategic KOL plans to provide needs-based and value-added services.
Identify and build collaborations with KOLs/OLs, investigators, study coordinators, and other HCPs, etc within assigned territory for medical education and potential clinical research opportunities.
Liaise with CRO, Clin Ops, and Study Medical Monitor to provide site recommendations based on prior knowledge of territory/investigators/allied health; participate in SIVs.
Leverage past relationships to ensure interest and commitment from sites/investigators for study enrolment and open communication re: feedback to sponsor.
Fully versed in all aspects of the protocol and program to answer immediate questions (Safety and specific patient eligibility questions)
Provide feedback on specific sites and regional trends/thoughts/paradigms to identify and/or inform potential protocol amendments, accrual barriers, patient/study subject identification
Participate in therapeutic advisory groups or Steering Committees and internal project teams, etc.
Deliver expert educational presentations in a variety of settings and obtain feedback that can be communicated throughout the organization.
Establish relationships with all rare-disease treaters on companies KOL list in territory; Supplement KOL list.
Acts as a local medical and scientific resource for the medical community.

Requirements for Clinical Trial Liaison:
BSc in Life Sciences. Advanced Degree (MD, PhD, PharmD, MSc) in relevant therapeutic area.
5+ years of relevant clinical experience in the pharma / biotech industry in pulmonology, cardiology, respiratory, and/or rare diseases.
3+ years’ experience as a Clinical Trial Liaison or Medical Science Liaison is preferred.
Broad clinical trials experience; including study start-up, patient recruitment and clinical trial execution.
Prior knowledge of European territory including established relationships with KOLs/OLs, PIs, etc., and strong network within the Pulmonology and/or Cardiology community.
Superb communicator of technical and scientific information. Multilingual a plus.
Valid passport enabling travel throughout EU region and internationally without restriction, as required.
Exhibits high motivation and high energy level, self-starter.

For further details, please contact Larry on +353 1 – 2302400 /

The RFT Group, BioPharmaceutical Division specialise exclusively in the recruitment of scientists, engineers and executives for the biotechnology, pharmaceutical and medical device sectors.

Follow us on: Facebook, Linked-in, twitter